The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has now approved the first domestically manufactured mRNA vaccine, Moderna’s Covid-19 Spikevax, for this year’s NHS vaccine campaign.
This groundbreaking drug will be supplied from the Moderna Innovation and Technology Centre in Harwell, Oxfordshire, a facility poised to produce millions of cutting-edge mRNA vaccines.